Literature DB >> 11355012

Mechanisms and consequences of Na+,K+-pump regulation by insulin and leptin.

G Sweeney1, A Klip.   

Abstract

Hormonal control of the Na+,K+-pump modulates membrane potential in mammalian cells, which in turn drives ion coupled transport processes and maintains cell volume and osmotic balance. Na+,K+-pump regulation is particularly important in the musculoskeletal, cardiovascular and renal systems. Decreased Na+,K+-pump activity can result in a rise in intracellular Na+ concentrations which in turn increase Na+/Ca2+ exchange, thereby raising intracellular Ca2+ levels. In cardiac and skeletal muscle, this could interfere with normal contractile activity. Similarly, in vascular smooth muscle the result would be resistance to vasodilation. Inhibition of the Na+,K+-pump can also reduce the driving force for renal tubular Na+ reabsorption, elevating Na+ excretion. By virtue of decreasing the membrane potential, thus allowing more efficient depolarization of nerve endings and by increasing intracellular Ca2+, inhibition of the Na+,K+-pump can increase nervous tone. The ability of insulin to stimulate the Na+,K+-pump in various cells and tissues, and the physiological significance thereof, have been well documented. Much less is known about the effect of leptin on the Na+,K+-pump. We have shown that leptin inhibits Na+,K+-pump function in 3T3-L1 fibroblasts. Defects in insulin and leptin action are associated with diabetes and obesity, respectively, both of which are commonly associated with cardiovascular complications. In this review we discuss the mechanisms of Na+,K+-pump regulation by insulin and leptin and highlight how, when they fail, they may contribute to the pathophysiology of hypertension associated with diabetes and obesity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355012

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  16 in total

1.  Marinobufagenin, an endogenous inhibitor of alpha-1 Na/K-ATPase, is a novel factor in pathogenesis of diabetes mellitus.

Authors:  Y Y Bagrov; N B Manusova; I A Egorova; E V Frolova; O V Fedorova; A Y Bagrov
Journal:  Dokl Biol Sci       Date:  2005 Sep-Oct

2.  Activation of the Na+/K+-ATPase by insulin and glucose as a putative negative feedback mechanism in pancreatic beta-cells.

Authors:  M Düfer; D Haspel; P Krippeit-Drews; L Aguilar-Bryan; J Bryan; G Drews
Journal:  Pflugers Arch       Date:  2008-10-03       Impact factor: 3.657

Review 3.  Sodium MRI: methods and applications.

Authors:  Guillaume Madelin; Jae-Seung Lee; Ravinder R Regatte; Alexej Jerschow
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2014-03-07       Impact factor: 9.795

Review 4.  Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal and extrarenal potassium transport.

Authors:  Florian Lang; Volker Vallon
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

5.  Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats.

Authors:  Olga V Fedorova; Artem V Fadeev; Yulia N Grigorova; Courtney A Marshall; Valentina Zernetkina; Nikolai I Kolodkin; Natalia I Agalakova; Alexandra O Konradi; Edward G Lakatta; Alexei Y Bagrov
Journal:  J Cardiovasc Pharmacol       Date:  2019-11       Impact factor: 3.105

6.  SGK1 dependence of insulin induced hypokalemia.

Authors:  Krishna M Boini; Dirk Graf; Dietmar Kuhl; Dieter Häussinger; Florian Lang
Journal:  Pflugers Arch       Date:  2008-07-30       Impact factor: 3.657

7.  Poly(methyl methacrylate)s with pendant calixpyrroles and crown ethers: polymeric extractants for potassium halides.

Authors:  Abdullah Aydogan; Daniel J Coady; Sung Kuk Kim; Ahmet Akar; Christopher W Bielawski; Manuel Marquez; Jonathan L Sessler
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

8.  Endogenous sodium pump inhibitors, diabetes mellitus and preeclampsia Preliminary observations and a hypothesis.

Authors:  Yakov Y Bagrov; Natalia B Manusova; Elena V Frolova; Irina A Egorova; Vladimir A Kashkin; Natalia I Tapilskaya; Olga V Fedorova; Alexei Y Bagrov
Journal:  Pathophysiology       Date:  2007-10-17

9.  Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency.

Authors:  R Lanzi; S C Previtali; V Sansone; M Scavini; M Fortunato; E Gatti; G Meola; E Bosi; M Losa
Journal:  J Endocrinol Invest       Date:  2007-04       Impact factor: 4.256

Review 10.  Biomedical applications of sodium MRI in vivo.

Authors:  Guillaume Madelin; Ravinder R Regatte
Journal:  J Magn Reson Imaging       Date:  2013-05-30       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.